Skip NavigationSkip to Content

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates

  1. Author:
    Dross, Sandra
    Venkataraman, Rasika
    Patel, Shabnum
    Huang, Meei-Li
    Bollard, Catherine M
    Rosati,Margherita
    Pavlakis,George
    Felber,Barbara
    Bar, Katharine J
    Shaw, George M
    Jerome, Keith R
    Mullins, James I
    Kiem, Hans-Peter
    Fuller, Deborah Heydenburg
    Peterson, Christopher W
  2. Author Address

    Department of Microbiology, University of Washington, Seattle, WA, United States., Washington National Primate Research Center, Seattle, WA, United States., Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, United States., Center for Cancer and Immunology Research, Children 39;s National Hospital and Department of Pediatrics, The George Washington University, Washington, DC, United States., Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States., Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, MD, United States., Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, MD, United States., Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Center, Seattle, WA, United States., Department of Medicine, University of Washington, Seattle, WA, United States., Department of Global Health, University of Washington, Seattle, WA, United States.,
    1. Year: 2023
    2. Epub Date: 2023 05 03
  1. Journal: Frontiers in Immunology
    1. 14
    2. Pages: 1188018
  2. Type of Article: Article
  3. Article Number: 1188018
  1. Abstract:

    HIV-specific T cells are necessary for control of HIV-1 replication but are largely insufficient for viral clearance. This is due in part to these cells' recognition of immunodominant but variable regions of the virus, which facilitates viral escape via mutations that do not incur viral fitness costs. HIV-specific T cells targeting conserved viral elements are associated with viral control but are relatively infrequent in people living with HIV (PLWH). The goal of this study was to increase the number of these cells via an ex vivo cell manufacturing approach derived from our clinically-validated HIV-specific expanded T-cell (HXTC) process. Using a nonhuman primate (NHP) model of HIV infection, we sought to determine i) the feasibility of manufacturing ex vivo-expanded virus-specific T cells targeting viral conserved elements (CE, CE-XTCs), ii) the in vivo safety of these products, and iii) the impact of simian/human immunodeficiency virus (SHIV) challenge on their expansion, activity, and function. NHP CE-XTCs expanded up to 10-fold following co-culture with the combination of primary dendritic cells (DCs), PHA blasts pulsed with CE peptides, irradiated GM-K562 feeder cells, and autologous T cells from CE-vaccinated NHP. The resulting CE-XTC products contained high frequencies of CE-specific, polyfunctional T cells. However, consistent with prior studies with human HXTC and these cells' predominant CD8+ effector phenotype, we did not observe significant differences in CE-XTC persistence or SHIV acquisition in two CE-XTC-infused NHP compared to two control NHP. These data support the safety and feasibility of our approach and underscore the need for continued development of CE-XTC and similar cell-based strategies to redirect and increase the potency of cellular virus-specific adaptive immune responses. Copyright © 2023 Dross, Venkataraman, Patel, Huang, Bollard, Rosati, Pavlakis, Felber, Bar, Shaw, Jerome, Mullins, Kiem, Fuller and Peterson.

    See More

External Sources

  1. DOI: 10.3389/fimmu.2023.1188018
  2. PMID: 37207227
  3. PMCID: PMC10189133

Library Notes

  1. Fiscal Year: FY2022-2023
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel